Compare Bath & Body Works Inc (BBWI) vs BioNTech SE - ADR (BNTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bath & Body Works Inc vs BioNTech SE - ADR — how do they compare? Bath & Body Works Inc trades at $18.9 (market cap $3.81B), while BioNTech SE - ADR trades at $92.23 (market cap $23.31B). The key difference: BioNTech SE - ADR is far larger — about 6.1× Bath & Body Works Inc's market cap, and Bath & Body Works Inc pays a 4.24% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BBWI | BNTX | |
|---|---|---|
Market Cap | $3.81B | $23.31B |
Sector | Consumer Cyclical | Health |
52-Week High | $31.87 | $119.34 |
52-Week Low | $14.85 | $83.89 |
Enterprise Value | $7.70B | $6.60B |
Dividend Yield | 4.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bath & Body Works Inc
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →
